Trial Outcomes & Findings for Pulsed Electromagnetic Fields for Postoperative Analgesia: A Randomized, Triple-Masked, Sham-Controlled Pilot Study (NCT NCT05399355)

NCT ID: NCT05399355

Last Updated: 2024-07-31

Results Overview

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale. The outcome will the mean value of daily average pain scores measured with the Numeric Rating Scale

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

119 participants

Primary outcome timeframe

Mean value of the average daily pain measured on postoperative days 1, 2, 3, and 7

Results posted on

2024-07-31

Participant Flow

Participant milestones

Participant milestones
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Overall Study
STARTED
59
60
Overall Study
COMPLETED
59
60
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Total
n=119 Participants
Total of all reporting groups
Age, Continuous
57 years
STANDARD_DEVIATION 15 • n=59 Participants
59 years
STANDARD_DEVIATION 16 • n=60 Participants
58 years
STANDARD_DEVIATION 15 • n=119 Participants
Sex: Female, Male
Female
34 Participants
n=59 Participants
44 Participants
n=60 Participants
78 Participants
n=119 Participants
Sex: Female, Male
Male
25 Participants
n=59 Participants
16 Participants
n=60 Participants
41 Participants
n=119 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
59 participants
n=59 Participants
60 participants
n=60 Participants
119 participants
n=119 Participants
Height
170 cm
STANDARD_DEVIATION 10 • n=59 Participants
169 cm
STANDARD_DEVIATION 10 • n=60 Participants
169 cm
STANDARD_DEVIATION 10 • n=119 Participants
Weight
78 kg
STANDARD_DEVIATION 19 • n=59 Participants
79 kg
STANDARD_DEVIATION 17 • n=60 Participants
78 kg
STANDARD_DEVIATION 18 • n=119 Participants
Body Mass Index
27 kg/m^2
STANDARD_DEVIATION 5 • n=59 Participants
27 kg/m^2
STANDARD_DEVIATION 5 • n=60 Participants
27 kg/m^2
STANDARD_DEVIATION 5 • n=119 Participants
Surgery duration
86 minutes
STANDARD_DEVIATION 29 • n=59 Participants
93 minutes
STANDARD_DEVIATION 39 • n=60 Participants
89 minutes
STANDARD_DEVIATION 34 • n=119 Participants
Breast Surgery
14 Participants
n=59 Participants
15 Participants
n=60 Participants
29 Participants
n=119 Participants
Cholecystectomy
7 Participants
n=59 Participants
6 Participants
n=60 Participants
13 Participants
n=119 Participants
Hernia
8 Participants
n=59 Participants
9 Participants
n=60 Participants
17 Participants
n=119 Participants
Hip arthroplasty
15 Participants
n=59 Participants
15 Participants
n=60 Participants
30 Participants
n=119 Participants
Knee arthroplasty
15 Participants
n=59 Participants
15 Participants
n=60 Participants
30 Participants
n=119 Participants
Adductor Canal block
15 Participants
n=59 Participants
15 Participants
n=60 Participants
30 Participants
n=119 Participants
Paravertebral block
14 Participants
n=59 Participants
15 Participants
n=60 Participants
29 Participants
n=119 Participants
Erector spinal plane block
0 Participants
n=59 Participants
1 Participants
n=60 Participants
1 Participants
n=119 Participants
Rectus sheath block
1 Participants
n=59 Participants
1 Participants
n=60 Participants
2 Participants
n=119 Participants
Transversus abdominis plane block
0 Participants
n=59 Participants
1 Participants
n=60 Participants
1 Participants
n=119 Participants
No peripheral nerve block
29 Participants
n=59 Participants
27 Participants
n=60 Participants
56 Participants
n=119 Participants

PRIMARY outcome

Timeframe: Mean value of the average daily pain measured on postoperative days 1, 2, 3, and 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale. The outcome will the mean value of daily average pain scores measured with the Numeric Rating Scale

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
2.4 score on a scale
Standard Deviation 1.6
2.6 score on a scale
Standard Deviation 1.7

PRIMARY outcome

Timeframe: Mean value of the worst daily pain measured on postoperative days 1, 2, 3, and 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale. The outcome will the mean value of daily worst pain scores measured with the Numeric Rating Scale

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
4.6 score on a scale
Standard Deviation 2.0
4.7 score on a scale
Standard Deviation 2.1

PRIMARY outcome

Timeframe: Cumulative opioid consumption queried on postoperative days 1, 2, 3, and 7

Total opioid consumption from recovery room discharge until the data collection phone call on postoperative day 7 (measured in oral oxycodone equivalents).

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Total OPIOID Consumption From Recovery Room Discharge Until the Data Collection Phone Call on Postoperative Day 7 (Measured in Oral Oxycodone Equivalents)
21 mg
Standard Deviation 24
17 mg
Standard Deviation 26

SECONDARY outcome

Timeframe: postoperative day 1

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
2.5 score on a scale
Standard Deviation 1.9
2.9 score on a scale
Standard Deviation 2.1

SECONDARY outcome

Timeframe: postoperative day 2

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
2.7 score on a scale
Standard Deviation 2
3.2 score on a scale
Standard Deviation 2

SECONDARY outcome

Timeframe: postoperative day 3

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
2.2 score on a scale
Standard Deviation 1.9
2.7 score on a scale
Standard Deviation 2.3

SECONDARY outcome

Timeframe: postoperative day 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
1.8 score on a scale
Standard Deviation 2
1.8 score on a scale
Standard Deviation 2.1

SECONDARY outcome

Timeframe: postoperative day 14

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
1.3 score on a scale
Standard Deviation 1.8
1 score on a scale
Standard Deviation 1.7

SECONDARY outcome

Timeframe: postoperative day 21

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
1 score on a scale
Standard Deviation 1.8
.7 score on a scale
Standard Deviation 1.4

SECONDARY outcome

Timeframe: postoperative day 28

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
.7 score on a scale
Standard Deviation 1.3
.7 score on a scale
Standard Deviation 1.4

SECONDARY outcome

Timeframe: postoperative day 180

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
AVERAGE Pain Measured With the Numeric Rating Scale
0 score on a scale
Standard Deviation 0
.1 score on a scale
Standard Deviation .5

SECONDARY outcome

Timeframe: postoperative day 1

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
5.1 score on a scale
Standard Deviation 2.1
5.6 score on a scale
Standard Deviation 2.4

SECONDARY outcome

Timeframe: postoperative day 2

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
5.2 score on a scale
Standard Deviation 2.4
5.7 score on a scale
Standard Deviation 2.6

SECONDARY outcome

Timeframe: postoperative day 3

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
4.3 score on a scale
Standard Deviation 2.7
4.6 score on a scale
Standard Deviation 2.7

SECONDARY outcome

Timeframe: postoperative day 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
3.6 score on a scale
Standard Deviation 2.6
3.3 score on a scale
Standard Deviation 2.9

SECONDARY outcome

Timeframe: postoperative day 14

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
2.5 score on a scale
Standard Deviation 2.6
1.9 score on a scale
Standard Deviation 2.2

SECONDARY outcome

Timeframe: postoperative day 21

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
1.6 score on a scale
Standard Deviation 2.4
1.4 score on a scale
Standard Deviation 2

SECONDARY outcome

Timeframe: postoperative day 28

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
1.3 score on a scale
Standard Deviation 2.1
1.2 score on a scale
Standard Deviation 1.9

SECONDARY outcome

Timeframe: postoperative day 180

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
WORST Pain Measured With the Numeric Rating Scale
.3 score on a scale
Standard Deviation 1.1
.4 score on a scale
Standard Deviation 1.1

SECONDARY outcome

Timeframe: postoperative day 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
LEAST Pain Measured With the Numeric Rating Scale
.7 score on a scale
Standard Deviation 1.6
.9 score on a scale
Standard Deviation 1.6

SECONDARY outcome

Timeframe: postoperative day 14

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
LEAST Pain Measured With the Numeric Rating Scale
.6 score on a scale
Standard Deviation 1.2
.4 score on a scale
Standard Deviation 1.2

SECONDARY outcome

Timeframe: postoperative day 21

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
LEAST Pain Measured With the Numeric Rating Scale
.5 score on a scale
Standard Deviation 1.2
.3 score on a scale
Standard Deviation 1.1

SECONDARY outcome

Timeframe: postoperative day 28

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
LEAST Pain Measured With the Numeric Rating Scale
.3 score on a scale
Standard Deviation .8
.2 score on a scale
Standard Deviation .8

SECONDARY outcome

Timeframe: postoperative day 7

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
CURRENT Pain Measured With the Numeric Rating Scale
1.6 score on a scale
Standard Deviation 1.9
1.4 score on a scale
Standard Deviation 2.2

SECONDARY outcome

Timeframe: postoperative day 14

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
CURRENT Pain Measured With the Numeric Rating Scale
1.1 score on a scale
Standard Deviation 1.8
.8 score on a scale
Standard Deviation 1.6

SECONDARY outcome

Timeframe: postoperative day 21

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
CURRENT Pain Measured With the Numeric Rating Scale
.7 score on a scale
Standard Deviation 1.5
.5 score on a scale
Standard Deviation 1.3

SECONDARY outcome

Timeframe: postoperative day 28

The numeric rating scale is a 0-10 Likert scale measuring pain level with 0 = no pain and 10 = worst imaginable pain scale.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
CURRENT Pain Measured With the Numeric Rating Scale
.5 score on a scale
Standard Deviation 1
.4 score on a scale
Standard Deviation 1.1

SECONDARY outcome

Timeframe: postoperative day 1

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
1.3 mg
Standard Deviation 1.7
1 mg
Standard Deviation 1.3

SECONDARY outcome

Timeframe: postoperative day 2

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
1.4 mg
Standard Deviation 1.7
1 mg
Standard Deviation 1.4

SECONDARY outcome

Timeframe: postoperative day 3

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
1.1 mg
Standard Deviation 1.8
1.1 mg
Standard Deviation 2.2

SECONDARY outcome

Timeframe: postoperative day 7

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
.5 mg
Standard Deviation .9
.7 mg
Standard Deviation 1.5

SECONDARY outcome

Timeframe: postoperative day 14

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
.4 mg
Standard Deviation .9
.3 mg
Standard Deviation .9

SECONDARY outcome

Timeframe: postoperative day 21

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
.1 mg
Standard Deviation .4
.2 mg
Standard Deviation .7

SECONDARY outcome

Timeframe: postoperative day 28

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
.2 mg
Standard Deviation .9
.1 mg
Standard Deviation .4

SECONDARY outcome

Timeframe: postoperative day 180

Opioid consumption of the previous 24 hours (measured in oral oxycodone equivalents)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Opioid Consumption of the Previous 24 Hours (Measured in Oral Oxycodone Equivalents)
0 mg
Standard Deviation 0
0 mg
Standard Deviation 0

SECONDARY outcome

Timeframe: postoperative day 7

The Brief pain Inventory short form interference subscale is an instrument specifically designed to assess pain and its impact on physical and emotional functioning using a scale of 0-70. The subscale is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale \[0=no interference;10=complete interference\]: general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life. The 7 responses for the 7 questions are totaled, producing a scale of 0-70, with 0 being preferred and 70 indicating worse functioning.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Brief Pain Inventory, Short Form (Interference Subscale)
2.7 score on a scale
Standard Deviation 3.1
1.8 score on a scale
Standard Deviation 2.8

SECONDARY outcome

Timeframe: postoperative day 14

The Brief pain Inventory short form interference subscale is an instrument specifically designed to assess pain and its impact on physical and emotional functioning using a scale of 0-70. The subscale is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale \[0=no interference;10=complete interference\]: general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life. The 7 responses for the 7 questions are totaled, producing a scale of 0-70, with 0 being preferred and 70 indicating worse functioning.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Brief Pain Inventory, Short Form (Interference Subscale)
1.7 score on a scale
Standard Deviation 2.7
1.1 score on a scale
Standard Deviation 2.3

SECONDARY outcome

Timeframe: postoperative day 21

The Brief pain Inventory short form interference subscale is an instrument specifically designed to assess pain and its impact on physical and emotional functioning using a scale of 0-70. The subscale is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale \[0=no interference;10=complete interference\]: general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life. The 7 responses for the 7 questions are totaled, producing a scale of 0-70, with 0 being preferred and 70 indicating worse functioning.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Brief Pain Inventory, Short Form (Interference Subscale)
1.1 score on a scale
Standard Deviation 2.3
.6 score on a scale
Standard Deviation 1.5

SECONDARY outcome

Timeframe: postoperative day 28

The Brief pain Inventory short form interference subscale is an instrument specifically designed to assess pain and its impact on physical and emotional functioning using a scale of 0-70. The subscale is comprised of 7 questions involving physical and emotional functioning using a 0-10 Likert scale \[0=no interference;10=complete interference\]: general activity, mood, walking ability, normal work, relations with other people, sleep and enjoyment of life. The 7 responses for the 7 questions are totaled, producing a scale of 0-70, with 0 being preferred and 70 indicating worse functioning.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Brief Pain Inventory, Short Form (Interference Subscale)
.6 score on a scale
Standard Deviation 1.5
.3 score on a scale
Standard Deviation 1.1

SECONDARY outcome

Timeframe: postoperative day 1

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.4 events of awakening
Standard Deviation 1
.4 events of awakening
Standard Deviation .9

SECONDARY outcome

Timeframe: postoperative day 2

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.8 events of awakening
Standard Deviation 1.9
.6 events of awakening
Standard Deviation 1.4

SECONDARY outcome

Timeframe: postoperative day 3

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.4 events of awakening
Standard Deviation 1
.3 events of awakening
Standard Deviation .6

SECONDARY outcome

Timeframe: postoperative day 7

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.7 events of awakening
Standard Deviation 1.7
.5 events of awakening
Standard Deviation .9

SECONDARY outcome

Timeframe: postoperative day 14

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.8 events of awakening
Standard Deviation 1.7
.2 events of awakening
Standard Deviation .7

SECONDARY outcome

Timeframe: postoperative day 21

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.4 events of awakening
Standard Deviation 1.2
.1 events of awakening
Standard Deviation .4

SECONDARY outcome

Timeframe: postoperative day 28

The number of times the participant awoke the previous night due to pain

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Awakenings Due to Pain
.5 events of awakening
Standard Deviation 1.2
.2 events of awakening
Standard Deviation .6

SECONDARY outcome

Timeframe: One single measure recorded on or following the day of surgery (whichever day patient is discharged)

Day relative to the day of surgery that patient was discharged from the hospital (e.g., same day is postoperative day 0, while the day following surgery is postoperative day 1) over the first postoperative week. The surgical service determines when patients are to be discharged using their own criteria which are not defined by the study.

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Hospitalization Duration Measured in Days
.3 Days
Standard Deviation .5
.3 Days
Standard Deviation .5

SECONDARY outcome

Timeframe: One measure take at the two-week postoperative check (approximately postoperative day 14)

Population: This data point was not able to be collected as participants did not return to the surgeon's office for measurement at 14 days as originally anticipated

The number of degrees of passive flexion achieved from a neutral position

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: One single measure recorded following the day of surgery

Day relative to the day of surgery that patient stopped using the intervention for (e.g., same day is postoperative day 0, while the day following surgery is postoperative day 1)

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Day Stopped Using Intervention
21.3 Days
Standard Deviation 7.8
23.4 Days
Standard Deviation 7.9

SECONDARY outcome

Timeframe: queried on postoperative day 28

Population: The question regarding the desirability of device use in a hypothetical future surgery was inadvertently excluded from the case report forms.

Would the patient want to use the device for a hypothetical surgery in the future (yes, no, or undecided)?

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Intraoperative (within the operating room)

Population: This variable was miscatagorized as an outcome measure, when it was measured PRIOR to randomization following surgery. Therefore, it is captured and reported in the baseline measurements as surgical duration.

The time of the surgical incision as recorded using military time format

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Intraoperative (within the operating room)

Population: This variable was miscatagorized as an outcome measure, when it was measured PRIOR to randomization following surgery. Therefore, it is captured and reported in the baseline measurements as surgical duration.

The time of the final suture insertion as recorded using military time format

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Intraoperative (within the operating room)

Population: This variable was miscatagorized as an outcome measure, when it was measured PRIOR to randomization following surgery. Therefore, it is captured and reported in the baseline measurements as surgical duration.

The time from surgical start to surgical stop measured in minutes and hours

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Postoperative day 1

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
6 Participants
3 Participants

SECONDARY outcome

Timeframe: Postoperative day 2

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
6 Participants
3 Participants

SECONDARY outcome

Timeframe: Postoperative day 3

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Postoperative day 7

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Postoperative day 14

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Postoperative day 21

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
0 Participants
0 Participants

SECONDARY outcome

Timeframe: Postoperative day 28

If a patient moves the anatomic location of one of the intervention devices since the last phone contact

Outcome measures

Outcome measures
Measure
Active Pulsed Shortwave Treatment With BioElectronics Model 088
n=59 Participants
Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088 Active Pulsed Shortwave Treatment with BioElectronics Model 088: Application of 7-30 days of nonthermal, pulsed shortwave (radiofrequency) therapy with BioElectronics Model 088
Sham Treatment
n=60 Participants
Application of 7-30 days of a nonfunctional sham device. Sham Treatment: Application of 7-30 days of a nonfunctional sham device(s)
Device Location Changes
0 Participants
0 Participants

Adverse Events

Active Pulsed Shortwave Treatment With BioElectronics Model 088

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Brian Ilfeld, MD, MS

University of California San Diego

Phone: (858) 220-5714

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place